retatrutide pcos Peptides for PCOS: Weight Loss & Hormonal Balance Rising use of GLP-1 medications

[DOI] [PubMed] [Google Scholar] 95.Fildes A, van Jaarsveld CH, Llewellyn CH, Fisher A, Cooke L, Wardle J

2008;34(Suppl 2):S73-S77

The development program of semaglutide 2.4 mg, STEP (Semaglutide Treatment Effect in People with obesity), consistently suggested an even greater BW lowering efficacy compared to SCALE 23

As a GIP receptor agonist, it may further enhance metabolic benefits and improve insulin sensitivity

If a compounded GLP-1 program is something you are considering, the time to have that provider conversation is now - not because of any promotional pressure, but because the information landscape is changing and an informed decision requires current information

However, severe cases may require prescription medications